These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
214 related articles for article (PubMed ID: 18606668)
21. Functional requirements for the lysosomal thiol reductase GILT in MHC class II-restricted antigen processing. Hastings KT; Lackman RL; Cresswell P J Immunol; 2006 Dec; 177(12):8569-77. PubMed ID: 17142755 [TBL] [Abstract][Full Text] [Related]
22. Interferon-gamma mediates antigen trafficking to MHC class II-positive late endosomes of enterocytes. Büning J; Schmitz M; Repenning B; Ludwig D; Schmidt MA; Strobel S; Zimmer KP Eur J Immunol; 2005 Mar; 35(3):831-42. PubMed ID: 15688349 [TBL] [Abstract][Full Text] [Related]
23. Immune responses to self peptides naturally presented by murine class II major histocompatibility complex molecules. Rider BJ; Fraga E; Yu Q; Singh B Mol Immunol; 1996; 33(7-8):625-33. PubMed ID: 8760274 [TBL] [Abstract][Full Text] [Related]
24. Antigen secreted from noncytosolic Listeria monocytogenes is processed by the classical MHC class I processing pathway. Zwickey HL; Potter TA J Immunol; 1999 Jun; 162(11):6341-50. PubMed ID: 10352246 [TBL] [Abstract][Full Text] [Related]
25. MHC class II antigen processing in B cells: accelerated intracellular targeting of antigens. Cheng PC; Steele CR; Gu L; Song W; Pierce SK J Immunol; 1999 Jun; 162(12):7171-80. PubMed ID: 10358163 [TBL] [Abstract][Full Text] [Related]
26. Induction of hyporesponsiveness to intact foreign protein via retroviral-mediated gene expression: the IgG scaffold is important for induction and maintenance of immune hyporesponsiveness. Kang Y; Melo M; Deng E; Tisch R; El-Amine M; Scott DW Proc Natl Acad Sci U S A; 1999 Jul; 96(15):8609-14. PubMed ID: 10411923 [TBL] [Abstract][Full Text] [Related]
27. Intracellular organelles involved in antigen processing and the binding of peptides to class II MHC molecules. Harding CV Semin Immunol; 1995 Dec; 7(6):355-60. PubMed ID: 8775461 [TBL] [Abstract][Full Text] [Related]
28. Malignant glioma cells use MHC class II transactivator (CIITA) promoters III and IV to direct IFN-gamma-inducible CIITA expression and can function as nonprofessional antigen presenting cells in endocytic processing and CD4(+) T-cell activation. Soos JM; Krieger JI; Stüve O; King CL; Patarroyo JC; Aldape K; Wosik K; Slavin AJ; Nelson PA; Antel JP; Zamvil SS Glia; 2001 Dec; 36(3):391-405. PubMed ID: 11746775 [TBL] [Abstract][Full Text] [Related]
29. Cutting edge: signals from the B lymphocyte antigen receptor regulate MHC class II containing late endosomes. Siemasko K; Eisfelder BJ; Williamson E; Kabak S; Clark MR J Immunol; 1998 Jun; 160(11):5203-8. PubMed ID: 9605114 [TBL] [Abstract][Full Text] [Related]
30. MHC class II loading of high or low affinity peptides directed by Ii/peptide fusion constructs: implications for T cell activation. Gregers TF; Fleckenstein B; Vartdal F; Roepstorff P; Bakke O; Sandlie I Int Immunol; 2003 Nov; 15(11):1291-9. PubMed ID: 14565927 [TBL] [Abstract][Full Text] [Related]
31. Absence of gamma-interferon-inducible lysosomal thiol reductase in melanomas disrupts T cell recognition of select immunodominant epitopes. Haque MA; Li P; Jackson SK; Zarour HM; Hawes JW; Phan UT; Maric M; Cresswell P; Blum JS J Exp Med; 2002 May; 195(10):1267-77. PubMed ID: 12021307 [TBL] [Abstract][Full Text] [Related]
32. Autophagy promotes MHC class II presentation of peptides from intracellular source proteins. Dengjel J; Schoor O; Fischer R; Reich M; Kraus M; Müller M; Kreymborg K; Altenberend F; Brandenburg J; Kalbacher H; Brock R; Driessen C; Rammensee HG; Stevanovic S Proc Natl Acad Sci U S A; 2005 May; 102(22):7922-7. PubMed ID: 15894616 [TBL] [Abstract][Full Text] [Related]
33. Infection of mouse bone marrow-derived dendritic cells with recombinant adenovirus vectors leads to presentation of encoded antigen by both MHC class I and class II molecules-potential benefits in vaccine design. Herrera OB; Brett S; Lechler RI Vaccine; 2002 Dec; 21(3-4):231-42. PubMed ID: 12450698 [TBL] [Abstract][Full Text] [Related]
34. Characterization of MHC class II-presented peptides generated from an antigen targeted to different endocytic compartments. Fernandes DM; Vidard L; Rock KL Eur J Immunol; 2000 Aug; 30(8):2333-43. PubMed ID: 10940924 [TBL] [Abstract][Full Text] [Related]
35. T cell responses to bluetongue virus are directed against multiple and identical CD4+ and CD8+ T cell epitopes from the VP7 core protein in mouse and sheep. Rojas JM; Rodríguez-Calvo T; Peña L; Sevilla N Vaccine; 2011 Sep; 29(40):6848-57. PubMed ID: 21807057 [TBL] [Abstract][Full Text] [Related]
36. A transporter associated with antigen-processing independent vacuolar pathway for the MHC class I-mediated presentation of endogenous transmembrane proteins. Tiwari N; Garbi N; Reinheckel T; Moldenhauer G; Hämmerling GJ; Momburg F J Immunol; 2007 Jun; 178(12):7932-42. PubMed ID: 17548631 [TBL] [Abstract][Full Text] [Related]
37. Disulfide reduction in major histocompatibility complex class II-restricted antigen processing by interferon-gamma-inducible lysosomal thiol reductase. Phan UT; Maric M; Cresswell P Methods Enzymol; 2002; 348():43-8. PubMed ID: 11885292 [TBL] [Abstract][Full Text] [Related]
38. Gilt required for RTL550-CYS-MOG to treat experimental autoimmune encephalomyelitis. Burrows GG; Meza-Romero R; Huan J; Sinha S; Mooney JL; Vandenbark AA; Offner H Metab Brain Dis; 2012 Jun; 27(2):143-9. PubMed ID: 22392628 [TBL] [Abstract][Full Text] [Related]
39. H2-M, a facilitator of MHC class II peptide loading, and its negative modulator H2-O are differentially expressed in response to proinflammatory cytokines. Walter W; Scheuer C; Lingnau K; Reichert TE; Schmitt E; Loos M; Maeurer MJ Immunogenetics; 2000 Aug; 51(10):794-804. PubMed ID: 10970094 [TBL] [Abstract][Full Text] [Related]
40. Native IgG2a(b) is barely antigenic to major histocompatibility complex class II-restricted T cells owing to inefficient internalization by professional antigen-presenting cells. Bartnes K; Hannestad K Immunology; 2000 Apr; 99(4):510-22. PubMed ID: 10792498 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]